Douglas S. Ingram

Companies

• Arrowhead PharmaceuticalsBoard member Feb 7, 2025 to now¹
• Relay TherapeuticsBoard member Jul 15, 2020 to now²
• Sarepta TherapeuticsBoard member Jun 28, 2017 to now³
• Sarepta TherapeuticsChief executive officer Jun 28, 2017 to Jul 29, 2026³
• Sarepta TherapeuticsPresident Jun 28, 2017 to Nov 6, 2023³
• Endo International plcBoard member May 9, 2016 to Jun 12, 2017⁴
• Skye Bioscience, Inc.Board member Jun 3, 2015 to Oct 22, 2015⁵
• Skye Bioscience, Inc.Vice chair Jun 3, 2015 to Oct 22, 2015⁵
• Allergan plcPresident Jan 27, 2014 to Mar 19, 2015⁶
• Allergan plcEVP, GC and Secretary Feb 8, 2006 to Feb 22, 2013⁷
• VolcomBoard member Aug 4, 2006 to Jun 24, 2011⁸

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Sarepta Therapeutics SRPT929,391 shares⁹$16.5M at $17.71Dec 7, 2025
• APArrowhead Pharmaceuticals ARWR46,215 shares¹⁰$2.6M at $56.73Dec 16, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Dec 16, 2025Granted 7,819 shares of Arrowhead Pharmaceuticals¹⁰
• Dec 7, 2025Granted 269,542 shares of Sarepta Therapeutics⁹
• Dec 7, 2025Granted 96,541 shares of Sarepta Therapeutics⁹
• Dec 7, 2025Granted 73,001 shares of Sarepta Therapeutics⁹
• Dec 7, 2025Granted 50,000 shares of Sarepta Therapeutics⁹
• Dec 7, 2025Granted 50,000 shares of Sarepta Therapeutics⁹
• Feb 6, 2025Granted 38,396 shares at $20.09 of Arrowhead Pharmaceuticals¹¹
• Nov 3, 2023Bought 200 shares at $81.26 of Sarepta Therapeutics¹²
• Nov 3, 2023Bought 3,884 shares at $80.33 of Sarepta Therapeutics¹²
• Nov 3, 2023Bought 11,060 shares at $79.70 of Sarepta Therapeutics¹²
• Nov 3, 2023Bought 10,081 shares at $78.57 of Sarepta Therapeutics¹²
• Nov 17, 2021Bought 25,026 shares at $79.94 of Sarepta Therapeutics¹³